Page last updated: 2024-10-25

clomipramine and Embryopathies

clomipramine has been researched along with Embryopathies in 1 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bromiker, R1
Kaplan, M1

Other Studies

1 other study available for clomipramine and Embryopathies

ArticleYear
Apparent intrauterine fetal withdrawal from clomipramine hydrochloride.
    JAMA, 1994, Dec-14, Volume: 272, Issue:22

    Topics: Clomipramine; Female; Fetal Diseases; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complicati

1994